HIMS & HERS HEALTH INC (HIMS) Stock Fundamental Analysis
USA - New York Stock Exchange - NYSE:HIMS - US4330001060 - Common Stock
32.47 USD
-0.57 (-1.73%)
32.39 USD
-0.08 (-0.25%)
HIMS gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 101 industry peers in the Health Care Providers & Services industry. HIMS has only an average score on both its financial health and profitability. HIMS shows excellent growth, but is valued quite expensive already.
1. Profitability
1.1 Basic Checks
HIMS had positive earnings in the past year.
In the past year HIMS had a positive cash flow from operations.
In the past 5 years HIMS reported 4 times negative net income.
In multiple years HIMS reported negative operating cash flow during the last 5 years.
1.2 Ratios
The Return On Assets of HIMS (5.99%) is better than 82.18% of its industry peers.
The Return On Equity of HIMS (23.03%) is better than 90.10% of its industry peers.
HIMS has a Return On Invested Capital of 5.84%. This is in the better half of the industry: HIMS outperforms 60.40% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 5.99% | ||
| ROE | 23.03% | ||
| ROIC | 5.84% |
ROA(3y)-1.82%
ROA(5y)-6.51%
ROE(3y)-0.49%
ROE(5y)-7.04%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
Looking at the Profit Margin, with a value of 6.05%, HIMS belongs to the top of the industry, outperforming 81.19% of the companies in the same industry.
With a decent Operating Margin value of 5.96%, HIMS is doing good in the industry, outperforming 65.35% of the companies in the same industry.
HIMS's Gross Margin of 75.01% is amongst the best of the industry. HIMS outperforms 90.10% of its industry peers.
HIMS's Gross Margin has improved in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 5.96% | ||
| PM (TTM) | 6.05% | ||
| GM | 75.01% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.84%
GM growth 5YN/A
2. Health
2.1 Basic Checks
HIMS has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
The number of shares outstanding for HIMS has been increased compared to 1 year ago.
The number of shares outstanding for HIMS has been increased compared to 5 years ago.
HIMS has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
2.2 Solvency
An Altman-Z score of 4.00 indicates that HIMS is not in any danger for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 4.00, HIMS is in the better half of the industry, outperforming 76.24% of the companies in the same industry.
HIMS has a debt to FCF ratio of 8.13. This is a slightly negative value and a sign of low solvency as HIMS would need 8.13 years to pay back of all of its debts.
HIMS has a Debt to FCF ratio (8.13) which is in line with its industry peers.
HIMS has a Debt/Equity ratio of 1.67. This is a high value indicating a heavy dependency on external financing.
Looking at the Debt to Equity ratio, with a value of 1.67, HIMS is doing worse than 69.31% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.67 | ||
| Debt/FCF | 8.13 | ||
| Altman-Z | 4 |
ROIC/WACC0.65
WACC8.95%
2.3 Liquidity
HIMS has a Current Ratio of 1.88. This is a normal value and indicates that HIMS is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 1.88, HIMS is in the better half of the industry, outperforming 76.24% of the companies in the same industry.
HIMS has a Quick Ratio of 1.64. This is a normal value and indicates that HIMS is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 1.64, HIMS is in the better half of the industry, outperforming 66.34% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.88 | ||
| Quick Ratio | 1.64 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 22.73% over the past year.
HIMS shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 60.35% yearly.
HIMS shows a strong growth in Revenue. In the last year, the Revenue has grown by 78.02%.
Measured over the past years, HIMS shows a very strong growth in Revenue. The Revenue has been growing by 75.77% on average per year.
EPS 1Y (TTM)22.73%
EPS 3YN/A
EPS 5Y60.35%
EPS Q2Q%-81.25%
Revenue 1Y (TTM)78.02%
Revenue growth 3Y75.77%
Revenue growth 5YN/A
Sales Q2Q%49.16%
3.2 Future
HIMS is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 41.75% yearly.
Based on estimates for the next years, HIMS will show a very strong growth in Revenue. The Revenue will grow by 21.08% on average per year.
EPS Next Y-12.6%
EPS Next 2Y5.34%
EPS Next 3Y13.84%
EPS Next 5Y41.75%
Revenue Next Year60.27%
Revenue Next 2Y37.63%
Revenue Next 3Y31.12%
Revenue Next 5Y21.08%
3.3 Evolution
Although the future EPS growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
4. Valuation
4.1 Price/Earnings Ratio
With a Price/Earnings ratio of 60.13, HIMS can be considered very expensive at the moment.
The rest of the industry has a similar Price/Earnings ratio as HIMS.
Compared to an average S&P500 Price/Earnings ratio of 26.51, HIMS is valued quite expensively.
Based on the Price/Forward Earnings ratio of 54.18, the valuation of HIMS can be described as expensive.
HIMS's Price/Forward Earnings ratio is in line with the industry average.
HIMS is valuated expensively when we compare the Price/Forward Earnings ratio to 23.13, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 60.13 | ||
| Fwd PE | 54.18 |
4.2 Price Multiples
HIMS's Enterprise Value to EBITDA ratio is in line with the industry average.
HIMS's Price/Free Cash Flow is on the same level as the industry average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 61.86 | ||
| EV/EBITDA | 42.74 |
4.3 Compensation for Growth
The decent profitability rating of HIMS may justify a higher PE ratio.
A more expensive valuation may be justified as HIMS's earnings are expected to grow with 13.84% in the coming years.
PEG (NY)N/A
PEG (5Y)1
EPS Next 2Y5.34%
EPS Next 3Y13.84%
5. Dividend
5.1 Amount
No dividends for HIMS!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
32.47
-0.57 (-1.73%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners94.02%
Inst Owner Change15.86%
Ins Owners5.88%
Ins Owner Change-3.41%
Market Cap7.39B
Revenue(TTM)2.21B
Net Income(TTM)133.79M
Analysts67.62
Price Target46.4 (42.9%)
Short Float %31.63%
Short Ratio3.07
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-16.62%
Min EPS beat(2)-43.53%
Max EPS beat(2)10.29%
EPS beat(4)3
Avg EPS beat(4)8.39%
Min EPS beat(4)-43.53%
Max EPS beat(4)62.17%
EPS beat(8)7
Avg EPS beat(8)149.86%
EPS beat(12)10
Avg EPS beat(12)106.48%
EPS beat(16)12
Avg EPS beat(16)73.87%
Revenue beat(2)1
Avg Revenue beat(2)-0.98%
Min Revenue beat(2)-3.17%
Max Revenue beat(2)1.2%
Revenue beat(4)3
Avg Revenue beat(4)1.27%
Min Revenue beat(4)-3.17%
Max Revenue beat(4)6.75%
Revenue beat(8)6
Avg Revenue beat(8)1.26%
Revenue beat(12)9
Avg Revenue beat(12)1.39%
Revenue beat(16)13
Avg Revenue beat(16)3.12%
PT rev (1m)-5.57%
PT rev (3m)-9.7%
EPS NQ rev (1m)-65.22%
EPS NQ rev (3m)-81.79%
EPS NY rev (1m)-21.88%
EPS NY rev (3m)-23.52%
Revenue NQ rev (1m)0.02%
Revenue NQ rev (3m)-1.96%
Revenue NY rev (1m)0.34%
Revenue NY rev (3m)0.29%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 60.13 | ||
| Fwd PE | 54.18 | ||
| P/S | 3.34 | ||
| P/FCF | 61.86 | ||
| P/OCF | 22.74 | ||
| P/B | 12.72 | ||
| P/tB | 58.29 | ||
| EV/EBITDA | 42.74 |
EPS(TTM)0.54
EY1.66%
EPS(NY)0.6
Fwd EY1.85%
FCF(TTM)0.52
FCFY1.62%
OCF(TTM)1.43
OCFY4.4%
SpS9.71
BVpS2.55
TBVpS0.56
PEG (NY)N/A
PEG (5Y)1
Graham Number5.57
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 5.99% | ||
| ROE | 23.03% | ||
| ROCE | 7.39% | ||
| ROIC | 5.84% | ||
| ROICexc | 9.03% | ||
| ROICexgc | 14.91% | ||
| OM | 5.96% | ||
| PM (TTM) | 6.05% | ||
| GM | 75.01% | ||
| FCFM | 5.4% |
ROA(3y)-1.82%
ROA(5y)-6.51%
ROE(3y)-0.49%
ROE(5y)-7.04%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.84%
GM growth 5YN/A
F-Score3
Asset Turnover0.99
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.67 | ||
| Debt/FCF | 8.13 | ||
| Debt/EBITDA | 5.57 | ||
| Cap/Depr | 484.08% | ||
| Cap/Sales | 9.3% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 186.53% | ||
| Profit Quality | 89.31% | ||
| Current Ratio | 1.88 | ||
| Quick Ratio | 1.64 | ||
| Altman-Z | 4 |
F-Score3
WACC8.95%
ROIC/WACC0.65
Cap/Depr(3y)228.03%
Cap/Depr(5y)N/A
Cap/Sales(3y)2.66%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)22.73%
EPS 3YN/A
EPS 5Y60.35%
EPS Q2Q%-81.25%
EPS Next Y-12.6%
EPS Next 2Y5.34%
EPS Next 3Y13.84%
EPS Next 5Y41.75%
Revenue 1Y (TTM)78.02%
Revenue growth 3Y75.77%
Revenue growth 5YN/A
Sales Q2Q%49.16%
Revenue Next Year60.27%
Revenue Next 2Y37.63%
Revenue Next 3Y31.12%
Revenue Next 5Y21.08%
EBIT growth 1Y190.64%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year351.26%
EBIT Next 3Y90.18%
EBIT Next 5Y58.35%
FCF growth 1Y344.61%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y625.93%
OCF growth 3YN/A
OCF growth 5YN/A
HIMS & HERS HEALTH INC / HIMS FAQ
What is the ChartMill fundamental rating of HIMS & HERS HEALTH INC (HIMS) stock?
ChartMill assigns a fundamental rating of 5 / 10 to HIMS.
What is the valuation status of HIMS & HERS HEALTH INC (HIMS) stock?
ChartMill assigns a valuation rating of 2 / 10 to HIMS & HERS HEALTH INC (HIMS). This can be considered as Overvalued.
What is the profitability of HIMS stock?
HIMS & HERS HEALTH INC (HIMS) has a profitability rating of 6 / 10.
What is the financial health of HIMS & HERS HEALTH INC (HIMS) stock?
The financial health rating of HIMS & HERS HEALTH INC (HIMS) is 4 / 10.